Acetylcysteine
Who holds supplier records for Acetylcysteine? 13 organisations hold a current record for Acetylcysteine: an active US FDA Type II Drug Master File or a CEP. 10 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: China (5), Italy (1), Spain (1), Japan (1) and 3 other countries (3); not recorded for 2.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Acetylcysteine: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/acetylcysteine
Reading the evidence
- 13 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 5 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
- US product patents listed
The latest patent listed in the FDA Orange Book for an approved product containing Acetylcysteine expires 6 Apr 2032. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.
Current records (13)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Acetylcysteine. Country is the organisation's recorded country, not necessarily the manufacturing site.
- FIS FABBRICA ITALIANA SINTETICI SPAItalyCEP Company GMP cert on recordActive DMF 5091 · latest filing Jul 1983
- MOEHS IBERICA SLSpainCEPActive DMF 14304 · latest filing Jul 1999
- NIPPON RIKA CO LTDJapanCEPActive DMF 21789 · latest filing Jul 2008
- ZHEJIANG JINHUA CONBA BIO-PHARM CO LTDChinaCEP Company GMP cert on recordActive DMF 40248 · latest filing Aug 2024
- Fujian South Pharmaceutical Co. Ltd.ChinaActive DMF 37947 · latest filing Jun 2023
- SHANXI YANGHE PHARMACEUTICAL CO LTDActive DMF 41591 · latest filing Apr 2025
- Zhejiang Haizhou Pharmaceutical Co., Ltd.ChinaActive DMF 42822 · latest filing Oct 2025
- NIPPON PROTEIN CO LTDCEP
- GermanyCEP Company GMP cert on record
- Seven Star Pharmaceutical Co., Ltd.TaiwanCEP
- ChinaCEP Company GMP cert on record
- FranceCEP Company GMP cert on record
- ZHEJIANG CDMO PHARMACEUTICAL CO., LTDChinaCEPValid CEP holder (EDQM); not necessarily the manufacturer
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (10)
Certificates of Suitability on the EDQM register for Acetylcysteine, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 15 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| WUHAN GRAND HOYO CO., LTD. Wuhan | CN | CEP 2022-064 - Rev 03 Acetylcysteine | Jul 2026 | — |
| MOEHS IBERICA S.L. Rubi | ES | CEP 1996-002 - Rev 07 Acetylcysteine | Jun 2026 | — |
| SEVEN STAR PHARMACEUTICAL CO., LTD. New Taipei | TW | CEP 2025-647 - Rev 00 Acetylcysteine, Process II | Jun 2026 | — |
| ZHEJIANG JINHUA CONBA BIO-PHARM. CO., LTD. Jinhua | CN | CEP 2024-368 - Rev 00 Acetylcysteine | Apr 2026 | — |
| ZHEJIANG CDMO PHARMACEUTICAL CO., LTD Jinhua | CN | CEP 2024-393 - Rev 00 Acetylcysteine | Nov 2025 | — |
| ZACH SYSTEM Avrillé | FR | CEP 2016-311 - Rev 01 Acetylcysteine | Aug 2025 | Inspected Apr 2025 France |
| F.I.S. - FABBRICA ITALIANA SINTETICI S.P.A. Montecchio Maggiore | IT | R1-CEP 1996-070 - Rev 09 Acetylcysteine | Jul 2021 | — |
| PHARMAZELL GMBH Raubling | DE | R2-CEP 1995-028 - Rev 04 Acetylcysteine | Dec 2020 | — |
| Nippon Protein Co., Ltd. Ashikaga-shi | JP | R1-CEP 1996-080 - Rev 04 Acetylcysteine | Jun 2020 | — |
| Nippon Rika Co., Ltd. Tokyo | JP | R1-CEP 1998-098 - Rev 02 Acetylcysteine | May 2009 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
US product patents and exclusivity
The FDA Orange Book lists patents and exclusivities for specific approved products (20 listed products contain Acetylcysteine). The latest listed patent expires 6 Apr 2032. The latest listed exclusivity runs to 26 Nov 2027. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Acetylcysteine is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL600).
Chemical identity
- IUPAC name
- (2R)-2-acetamido-3-sulfanylpropanoic acid
- Canonical SMILES
- CC(=O)N[C@@H](CS)C(=O)O
- InChIKey
- PWKSKIMOESPYIA-BYPYZUCNSA-N
- Synonyms
- 5052, Acc-600, Acetadote, Acetilcisteina, Acetyl cysteine, Acetylcysteine, A-cys, Airbron, Broncholysin, Cetylev, En-cys, Fabrol
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Antidote; Antidote for Acetaminophen Overdose; Mucolytic
- Mechanism of action
- Reduction Activity
- Physiologic effect
- Decreased Respiratory Secretion Viscosity; Increased Glutathione Concentration
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Acetylcysteine?
13 organisations hold an active US FDA Type II Drug Master File or a CEP for Acetylcysteine: FIS FABBRICA ITALIANA SINTETICI SPA (Italy), MOEHS IBERICA SL (Spain), NIPPON RIKA CO LTD (Japan), ZHEJIANG JINHUA CONBA BIO-PHARM CO LTD (China), Fujian South Pharmaceutical Co. Ltd. (China), SHANXI YANGHE PHARMACEUTICAL CO LTD, Zhejiang Haizhou Pharmaceutical Co., Ltd. (China) and NIPPON PROTEIN CO LTD, and 5 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Acetylcysteine Drug Master Files are active?
FIS FABBRICA ITALIANA SINTETICI SPA (DMF 5091), MOEHS IBERICA SL (DMF 14304), NIPPON RIKA CO LTD (DMF 21789), ZHEJIANG JINHUA CONBA BIO-PHARM CO LTD (DMF 40248), Fujian South Pharmaceutical Co. Ltd. (DMF 37947), SHANXI YANGHE PHARMACEUTICAL CO LTD (DMF 41591) and Zhejiang Haizhou Pharmaceutical Co., Ltd. (DMF 42822). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
Does Acetylcysteine have a European Certificate of Suitability?
Yes. 10 organisations hold a valid CEP for Acetylcysteine on the EDQM register, including WUHAN GRAND HOYO CO., LTD. Wuhan (CN), MOEHS IBERICA S.L. Rubi (ES), SEVEN STAR PHARMACEUTICAL CO., LTD. New Taipei (TW), ZHEJIANG JINHUA CONBA BIO-PHARM. CO., LTD. Jinhua (CN), ZHEJIANG CDMO PHARMACEUTICAL CO., LTD Jinhua (CN) and ZACH SYSTEM Avrillé (FR) and 4 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
Does the FDA Orange Book list patents for products containing Acetylcysteine?
Yes. The latest patent listed for an approved US product containing Acetylcysteine expires 6 Apr 2032, across 20 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.
How do I qualify a Acetylcysteine supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Acetylcysteine?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.